Is the "$149 founding rate" real?

We could not find it. Vyvron's own intake catalog prices its cheapest injectable semaglutide at $249 and its cheapest product of any kind, a tirzepatide microdose, at $179 — no product sells at $149 or $199. The accompanying "100 of 100 founding spots left" counter is a fixed value written into the page code rather than a live inventory count, so it does not decrease as people sign up.

Is Vyvron's pricing monthly?

No — it bills every four weeks, which works out to thirteen charges a year rather than twelve. A $249 "monthly" plan is therefore $3,237 a year, not $2,988. The per-cycle figures themselves are accurate; just do not read them as calendar months.

What does Vyvron's longevity line actually cost?

The advertised "starting at $145/mo" is the price of its B12-MIC lipotropic shot. NAD+ costs $229 per four-week cycle in every route it offers — injection, nasal spray or oral — and injectable sermorelin is also $229.

Who prescribes and dispenses?

Vyvron does not say. It describes itself as an access platform connecting patients with "independent licensed medical providers" and "licensed pharmacy partners," and names none of them. It is explicit that it is not itself a medical provider or pharmacy.

Can I use Vyvron in any state?

It does not publish a state list. The one restriction it discloses is that compounded medications are not available to Mississippi residents. Confirm your own state before starting the evaluation.

Updated August 2026

Vyvron review

Certified, but the banner misleads

A LegitScript-certified access platform with clear regulatory disclaimers — running a founding-member countdown for a price that appears in none of its own products.

Our verdict

Vyvron is unusually careful in one respect and unusually loose in another. Its compliance copy is genuinely good: it states plainly that it is not a medical provider, pharmacy or insurance plan, that compounded medications are not FDA-approved and are not equivalent to branded products, and that eligibility and pricing are determined independently of it. It is LegitScript certified. But its homepage is built around a "Founding Member · First 100" countdown pitching $149 or $199 against struck-through prices, with a counter reading "100 of 100 founding spots left" that is a fixed value written into the page code rather than live inventory — and no product in Vyvron's own intake catalog sells at $149 or $199. The real floor is $179 for a tirzepatide microdose and $249 for injectable semaglutide, billed every four weeks. Good disclosures, unreliable prices.

Check availability →Semaglutide $249, tirzepatide $339, microdose $179 — per 4 weeks, 13 charges a year. The “$149 founding rate” matches no product.

Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.

At a glance

Category: GLP-1 telehealth
Access: Semaglutide $249, tirzepatide $339, microdose $179 — per 4 weeks, 13 charges a year. The “$149 founding rate” matches no product.
Medications: Compounded semaglutide · Compounded tirzepatide
Insurance: Cash-pay, no insurance
Visit: Quiz intake / Async intake
Availability: Not published; excludes Mississippi for compounded medications
LegitScript: Certified
Updated: August 2026

Popular alternative

Enhance MD

Lab-guided treatment under ongoing physician oversight

Check Enhance MD availability →

What it is

A telehealth access platform, not a clinic — Vyvron connects patients with independent licensed providers who decide whether to prescribe, with fulfillment through pharmacy partners it does not name. It sells compounded GLP-1s in standard and microdose form, NAD+ in three routes, injectable sermorelin and a B12-MIC lipotropic shot.

How it works

A short online evaluation, described as taking about 60 seconds, is reviewed by an independent licensed provider who determines eligibility at their sole clinical discretion. Vyvron is explicit that all medical decisions, prescriptions and pharmacy fulfillment sit with independent partners, and that it does not prescribe, practice medicine or operate as a pharmacy. It displays LegitScript certification with a verification link, and the seal identifier resolves against LegitScript's own asset service where invented identifiers are rejected. Subscriptions auto-renew until you cancel by email, effective at the end of the billing cycle with no fee. The company is registered as Vyvron LLC at an address in Sheridan, Wyoming that is a shared registered-agent address rather than an operating office. No state list is published; compounded medications are unavailable to Mississippi residents.

Pricing transparency

Read the catalog, not the banner. Vyvron's own intake payload prices injectable semaglutide at $249, injectable tirzepatide at $339, oral semaglutide at $279, a tirzepatide-and-L-carnitine microdose at $179, NAD+ at $229 in all three routes (injection, nasal spray, oral), injectable sermorelin at $229 and a B12-MIC shot at $145 — every one of them per four-week cycle, which means thirteen charges a year rather than twelve, so a "/month" reading understates the annual cost by about eight per cent. Against that, the marketing layer offers three different and unsupported figures. The homepage hero runs founding rates of $149 (against a struck-through $179) and $199 (against $249), neither of which matches any product. The tier cards advertise "Medical Weight Loss — starting at $199" and "Microdosing — starting at $179," of which only the microdose figure is real. And the longevity tier's "Starting at $145/mo" is the B12-MIC shot, not NAD+ or sermorelin, both of which are $229.

Branded vs compounded

Compounded, with better-than-average disclosure. Vyvron states that compounded medications are not reviewed by the FDA for safety, effectiveness or quality before marketing and "are not identical or equivalent to any FDA-approved branded medication," and adds that it does not imply any such equivalence — more precise than the usual boilerplate. Its catalog identifies the actual molecules rather than hiding behind brand names: the microdose product is tirzepatide with L-carnitine, the B12-MIC shot is methylcobalamin with methionine, inositol and choline. On evidence: sermorelin has a real growth-hormone-axis mechanism with thin long-term human outcome data; injected, intranasal and oral NAD+ have no controlled human outcome trials, and the randomized support belongs to the oral NR/NMN precursors as a biomarker result; lipotropic B12-MIC injections have no meaningful controlled evidence for fat loss. Low-dose or "microdose" GLP-1 protocols are a marketing construct rather than a studied regimen — the trial evidence for semaglutide and tirzepatide comes from full titration schedules.

Pros and watch-outs

What we like

LegitScript certified, with a working verification link
Unusually precise regulatory language — states explicitly that compounded medications are not equivalent to branded ones
Clear about what it is: not a medical provider, pharmacy or insurance plan
Its catalog names the actual molecules in each product, including the microdose composition
Cancel by email at the end of any cycle, with no fee
Discloses the Mississippi restriction on compounded medications up front

Watch-outs

The "$149 founding rate" matches no product in its own intake catalog — the real semaglutide floor is $249
The "100 of 100 founding spots left" counter is a fixed value in the page code, not live inventory
The advertised "longevity from $145/mo" is a B12-MIC shot; NAD+ and sermorelin are both $229
Billing is per four weeks — 13 charges a year — while the marketing reads as monthly
No pharmacy, clinician or medical group is named anywhere
No state list is published beyond the Mississippi exclusion
Its catalog is identical to Lighter You's, at identical prices, on a shared commerce backend

Best for

Buyers who want a LegitScript-certified route to a compounded GLP-1 or a single sermorelin protocol, and who will price the product from the intake rather than the homepage.

Who should look elsewhere

Anyone who wants to know which clinician and pharmacy are behind their prescription, anyone in Mississippi seeking compounded medication, or anyone who takes a countdown timer at face value.

The evidence behind what Vyvron prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.
Tirzepatide vs semaglutide for weight loss: what the trials actually support
Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.
Sermorelin: a real GHRH drug, read against the anti-aging pitch
An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.
NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

How Vyvron compares

A few alternatives worth a look, depending on what you’re optimizing for.

Lighter You
Buyers who want dietitian visits and coaching bundled into a GLP-1 plan
See Lighter You →
AurenRx
Buyers who want a named pharmacy and will read past the advertised headline price
See AurenRx →
the edit.
Buyers who want the practice, pharmacy and management company all named before they pay
See the edit. →

Compare all providers side by side →

Nadia Feldman

Access & cost · Reviewed and last verified August 2026

How we assessed this. This review reflects Aminoscope’s own read of Vyvron’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.

Frequently asked

Is the "$149 founding rate" real?: We could not find it. Vyvron's own intake catalog prices its cheapest injectable semaglutide at $249 and its cheapest product of any kind, a tirzepatide microdose, at $179 — no product sells at $149 or $199. The accompanying "100 of 100 founding spots left" counter is a fixed value written into the page code rather than a live inventory count, so it does not decrease as people sign up.
Is Vyvron's pricing monthly?: No — it bills every four weeks, which works out to thirteen charges a year rather than twelve. A $249 "monthly" plan is therefore $3,237 a year, not $2,988. The per-cycle figures themselves are accurate; just do not read them as calendar months.
What does Vyvron's longevity line actually cost?: The advertised "starting at $145/mo" is the price of its B12-MIC lipotropic shot. NAD+ costs $229 per four-week cycle in every route it offers — injection, nasal spray or oral — and injectable sermorelin is also $229.
Who prescribes and dispenses?: Vyvron does not say. It describes itself as an access platform connecting patients with "independent licensed medical providers" and "licensed pharmacy partners," and names none of them. It is explicit that it is not itself a medical provider or pharmacy.
Can I use Vyvron in any state?: It does not publish a state list. The one restriction it discloses is that compounded medications are not available to Mississippi residents. Confirm your own state before starting the evaluation.

Check availability →

Or compare every GLP-1 provider.